EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma

Stephan Forchhammer iD, Valentin Aebischer iD, Daniela Lenders, Christian M Seitz, Christopher Schroeder, Alexandra Liebmann, Michael Abele, Hannah Wild, Ewa Bien, Malgorzata Krawczyk, Dominik T Schneider iD, Ines B Brecht und 2 weitere

Pigment Cell & Melanoma Research · 2024

DOI: 10.1111/pcmr.13167 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von Stephan Forchhammer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Immunohistochemistry, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric melanomas are rare tumors that have clinical and histological differences from adult melanomas. In adult melanoma, the immunohistochemical marker PRAME is increasingly employed as a diagnostic adjunct. PRAME is also under investigation as a target structure for next‐generation immunotherapies including T‐cell engagers. Little is known about the characteristics of PRAME expression in pediatric melanoma. In this retrospective study, samples from 25 pediatric melanomas were compared with control groups of melanomas in young adults (18–30 years; n = 32), adult melanoma (>30 years, n = 30), and benign melanocytic nevi in children (0–18 years; n = 30) with regard to the immunohistochemical expression of PRAME (diffuse PRAME expression >75%/absolute expression). Pediatric melanomas show lower diffuse PRAME expression (4%) and lower absolute PRAME expression (25%) compared to young adult melanomas (15.6%/46.8%) and adult melanomas (50%/70%). A significant age‐dependent expression could be observed. An analysis of event‐free survival shows no prognostic role for PRAME in pediatric melanoma and young adult melanoma, but a significant association with diffuse PRAME expression in adulthood. The age dependency of PRAME expression poses a potential pitfall in the diagnostic application of melanocytic tumors in young patients and may limit therapeutic options within this age group. The immunohistochemical expression of the tumor‐associated antigen PRAME is an increasingly important diagnostic marker for melanocytic tumors and is gaining attention as a possible immunotherapeutic target in melanoma. As the available data primarily stem from adult melanoma, and given the clinical and histological distinctions in pediatric melanomas, our understanding of PRAME expression in this specific patient group remains limited. The age‐dependent low PRAME expression shown here constrains the use of this marker in pediatric melanoma and may also limit the use of immunotherapeutic strategies against PRAME in young patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunohistochemistryMelanomaSkin NeoplasmsAdolescentAdultAgedChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedYoung AdultAntigens, NeoplasmBiomarkers, TumorPrognosisRetrospective Studies

Stichwörter der Autor:innen

PRAMEage dependencydermatopathologyimmunohistochemistrypediatric melanomaprognostic factor

Substanzen

Antigens, NeoplasmBiomarkers, TumorPRAME protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Pediatric Hematology and Oncology, Children's Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Institute of Medical Genetics and Applied Genomics, Eberhard Karls University of Tübingen, Tübingen, Germany.
  • Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, Gdansk, Poland.
  • Clinic of Pediatrics, Dortmund Municipal Hospital, University Witten/Herdecke, Dortmund, Germany.

ORCID-Profile: Stephan Forchhammer, Valentin Aebischer, Dominik T Schneider, Matthias Hahn

Zitieren

APA

Forchhammer, S., Aebischer, V., Lenders, D., Seitz, C. M., Schroeder, C., Liebmann, A., Abele, M., Wild, H., Bien, E., Krawczyk, M., Schneider, D. T., Brecht, I. B., Flatz, L., & Hahn, M. (2024). Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13167

Vancouver

Forchhammer S, Aebischer V, Lenders D, Seitz CM, Schroeder C, Liebmann A, et al. Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13167

BibTeX
@article{Forchhammer2024,
  author = {Forchhammer, Stephan and Aebischer, Valentin and Lenders, Daniela and Seitz, Christian M and Schroeder, Christopher and Liebmann, Alexandra and Abele, Michael and Wild, Hannah and Bien, Ewa and Krawczyk, Malgorzata and Schneider, Dominik T and Brecht, Ines B and Flatz, Lukas and Hahn, Matthias},
  title = {Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma},
  journal = {Pigment Cell & Melanoma Research},
  year = {2024},
  doi = {10.1111/pcmr.13167}
}
Kostenlos starten →